MedPage Today: The case for organized post-COVID care
UC cardiologist discusses future care for COVID-19 survivors
As the world approaches the 6-month mark with the SARS-CoV-2 virus, hospitals have begun to organize after-care for survivors of severe COVID-19 even as long-term sequelae are still emerging. Medpage Today spoke with physicians across the nation about their plans for patients. Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, was interviewed for the story. Becker acknowledged that while some hospitals at the forefront of COVID-19 epicenters may be leading the way, others including academic health centers aren’t far behind in their plans.
Read the interview with Richard Becker, MD.
Learn more about Becker’s research on COVID-19.
Featured image at top: Richard Becker, MD, (center) shown with a colleague in the UC College of Medicine. Photo: Colleen Kelley/UC Creative + Brand.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.